REGULATED PRESS RELEASE published on 09/01/2025 at 07:00, 7 months 5 days ago Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil. Mise à jour détaillée du plan clinique et réglementaire visant à étendre le potentiel de BIO101 Biophytis Europe Essai Clinique BIO101 Obésité
REGULATED PRESS RELEASE published on 09/01/2025 at 07:00, 7 months 5 days ago Biophytis unveils Phase 2 Obesity Trial Strategy with BIO101 in Europe and Brazil Biophytis reveals Phase 2 Obesity Trial Strategy for BIO101 in Europe and Brazil, targeting muscle wasting in obese patients. Expanding therapeutic horizons and commercial prospects Biophytis Phase 2 BIO101 Muscle Wasting Obesity Trial
PRESS RELEASE published on 09/01/2025 at 07:00, 7 months 5 days ago Les actionnaires de WNS approuvent l’acquisition par Capgemini Les actionnaires de WNS approuvent l'acquisition par Capgemini. L'opération de 3,3 milliards de dollars vise à créer un leader mondial des Opérations Intelligentes Acquisition IA Capgemini WNS Opérations Intelligentes
PRESS RELEASE published on 09/01/2025 at 07:00, 7 months 5 days ago Acquisition of WNS approved by its shareholders Capgemini announces approval of WNS acquisition by its shareholders, creating a global leader in Agentic AI-powered Intelligent Operations. Closing expected by year-end amidst regulatory approvals Regulatory Approvals Shareholders Approval Capgemini WNS Acquisition AI-powered Operations
PRESS RELEASE published on 09/01/2025 at 06:59, 7 months 5 days ago Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil. Mise à jour détaillée du plan clinique et réglementaire, ambitions et enjeux commerciaux Biophytis Europe Essai Clinique BIO101 Obésité
PRESS RELEASE published on 09/01/2025 at 06:59, 7 months 5 days ago Biophytis unveils Phase 2 Obesity Trial Strategy with BIO101 in Europe and Brazil Biophytis unveils Phase 2 Obesity Trial Strategy for BIO101 in Europe and Brazil, targeting muscle wasting associated with obesity. The new program broadens potential and value-creation opportunities globally Biophytis Phase 2 BIO101 Muscle Wasting Obesity Trial
PRESS RELEASE published on 08/31/2025 at 18:00, 7 months 6 days ago Déclaration des transactions sur actions propres KLEA HOLDING annonce des rachats d'actions propres conformes au règlement MAR et présente son activité centrée sur l'acquisition, le développement et la digitalisation d'entreprises Acquisition Développement Digitalisation Rachats D'actions Klea Holding
PRESS RELEASE published on 08/31/2025 at 12:17, 7 months 6 days ago EQS-Adhoc: Gateway Real Estate AG: Value adjustments weigh on preliminary figures for fiscal year 2024 Gateway Real Estate AG announces value adjustments affecting preliminary figures for fiscal year 2024 due to real estate reassessment, impacting EBIT and EBT EBIT Fiscal Year 2024 EBT Gateway Real Estate AG Value Adjustments
PRESS RELEASE published on 08/30/2025 at 14:00, 7 months 7 days ago Sparta Releases Q3 2025 Financial Results Sparta Group (TSXV:SAY) releases financial results for Q3 2025 & 2024, highlights advancements in recycling, medical tech pilot, large Bay contract, innovation & carbon credit program Financial Results Medical Technology Sparta Group Recycling Carbon Credit Program
PRESS RELEASE published on 08/30/2025 at 02:10, 7 months 7 days ago GLG Life Tech Corporation Reports 2025 Second Quarter Financial Results GLG Life Tech Corporation announces financial results for the three and six months ended June 30, 2025, including revenue decrease of 22% and net income increase. Company emphasizes managing SG&A expenses Financial Results Revenue Decrease GLG Life Tech Corporation Net Income Increase SG&A Expenses
Published on 04/06/2026 at 15:15, 6 hours 9 minutes ago Datavault AI CEO Nathaniel T. Bradley to Deliver Flagship Keynotes on Breakthrough RWA Tokenization at CONV3RGENCE London and AssetRush × Zurich 2026
Published on 04/06/2026 at 14:02, 7 hours 22 minutes ago Black Iron annonce un placement privé d’unités pour un produit brut pouvant atteindre 1,7 million de dollars américains
Published on 04/06/2026 at 13:15, 8 hours 9 minutes ago Avino Announces Normal Course Issuer Bid for Common Shares
Published on 04/06/2026 at 13:00, 8 hours 24 minutes ago Revolve Signs Interconnection Agreement for 130 MW EL 24 Wind Project in Mexico
Published on 04/06/2026 at 19:00, 2 hours 24 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 30 MARS 2026 au 03 AVRIL 2026
Published on 04/06/2026 at 15:50, 5 hours 33 minutes ago Mesabi Metallics Secures $150 Million from Macquarie Group
Published on 04/06/2026 at 15:24, 5 hours 59 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/06/2026 at 15:23, 6 hours ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 04/06/2026 at 15:21, 6 hours 2 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 04/06/2026 at 15:00, 6 hours 24 minutes ago FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
Published on 04/06/2026 at 15:00, 6 hours 24 minutes ago FinanceWire intègre Certidox pour permettre la vérification des communiqués de presse, alors que les contenus falsifiés deviennent impossibles à distinguer de la réalité
Published on 04/03/2026 at 18:46, 3 days 2 hours ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 3 days 2 hours ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 3 days 3 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL